This study’s finding that activated, cycling CLL cells manifest a significant decline in BCL2 protein might be seen as surprising, given in light of other reports that, while not elevated, BCL2 protein did not decline following CLL activation in culture [28,29]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.